Keyword Suggestions

Results
 
 
Account Login
 
Username
 
 
 
Password
 
 
 
 
 

Library Navigation

 
 

Browse Conferences

 
 
 
133 Results Found, Showing 1 - 50
Sort By:
View:
Filter By:
Date/Time
Conference
Keyword
My Content
Start Date/Time:
End Date/Time:
 
Go
 
Conference
 
 
Go
Keywords:
 
 
Go
Show only the content that I own
 
 
February 5, 2010 - Friday
 
rating
100 - PARP Inhibitors in Breast and Ovarian Cancer 
Date/Time:
February 5, 2010   8:00am - 8:30am
 
Length:
45 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Lee S. Schwartzberg, MD, FACP (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
101 - HER2 and Predictive Prognostics 
Date/Time:
February 5, 2010   8:30am - 9:00am
 
Length:
33 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Linda D. Bosserman, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
102 - Ideal Duration of Adjuvant Hormone Therapy in Breast Cancer 
Date/Time:
February 5, 2010   9:05am - 9:35am
 
Length:
33 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Beverly Moy, MD, MPH (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
103 - Appropriate Use of Aromatase Inhibitors for Breast Cancer in Post-menopausal Women 
Date/Time:
February 5, 2010   9:35am - 10:05am
 
Length:
28 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Beverly Moy, MD, MPH (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
104 - EGFR Mutation Testing and How it May Influence Therapy in Patients with NSCLC 
Date/Time:
February 5, 2010   11:05am - 11:35am
 
Length:
80 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Corey J. Langer, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
105 - Pros and Cons of "Maintenance" Therapy in Patients Who Respond to Chemotherapy 
Date/Time:
February 5, 2010   11:40am - 12:10pm
 
Length:
102 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Corey J. Langer, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
106 - Public Policy Roundtable: Legislative Update, Implications of HC Reform 
Date/Time:
February 5, 2010   1:35pm - 2:35pm
 
Total Credits:
1.00 CE / 1.00 CME  
 
Speakers:
John Askins (Speaker Disclosure)
 
Matthew A. Farber, MA (Speaker Disclosure)
 
Shelagh Foster, Esq. (Speaker Disclosure)
 
Ted A. Okon, MBA (Speaker Disclosure)
 
Geoff Werth (Speaker Disclosure)
 
Format:
 
  Audio Only
 

 
rating
107 - Vitamin D: New Data 
Date/Time:
February 5, 2010   2:40pm - 3:10pm
 
Length:
30 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
T. Declan Walsh, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
108 - RAC Audits, "Incident to" Changes, Compendia, Red-Flag Rules: Challenges Ahead 
Date/Time:
February 5, 2010   2:40pm - 3:45pm
 
Length:
74 Slides  
 
Total Credits:
1.00 CE / 1.00 CME  
 
Speaker:
Roberta L. Buell (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
109 - Glioblastoma (Radiation Options) 
Date/Time:
February 5, 2010   3:15pm - 3:45pm
 
Length:
41 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Jondavid Pollock, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
110 - Comparative Effectiveness 
Date/Time:
February 5, 2010   4:30pm - 5:30pm
 
Length:
43 Slides  
 
Total Credits:
1.00 CE / 1.00 CME  
 
Speaker:
Les Paul, MD, MS (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
February 6, 2010 - Saturday
 
rating
111&113 - Risk-Adapted Therapies for Myelodysplastic Syndromes 
Date/Time:
February 6, 2010   8:20am - 8:50am
 
Length:
69 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
 
Format:
     
  Synched Audio / Slides
 

 
rating
114 - Prognostic Lab Sequencing and New Combos in CLL 
Date/Time:
February 6, 2010   9:25am - 9:55am
 
Length:
70 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Ilan Shapira, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
115 - Smoothing Patient Flow in the Infusion Room 
Date/Time:
February 6, 2010   9:25am - 9:55am
 
Length:
11 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Deanna Dominiak, RN, BSN, OCN (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
116 - Cultural Competencies 
Date/Time:
February 6, 2010   10:35am - 11:20am
 
Length:
33 Slides  
 
Total Credits:
1.00 CE / 1.00 CME  
 
Speaker:
Michael J. Fisch, MD, MPH (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
117 - Current Management of Myeloma Bone Disease and Potential Novel Therapeutic Targets for Treating Myeloma Bone Complications 
Date/Time:
February 6, 2010   11:25am - 11:55am
 
Length:
37 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
David Henry, FRCP (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
118 - Involving Patients in Health Care Reform 
Date/Time:
February 6, 2010   11:25am - 11:55am
 
Length:
21 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speakers:
Richard N. Frame, MD (Speaker Disclosure)
 
Rose Gerber (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
119 - Business Case for Quality Care 
Date/Time:
February 6, 2010   11:55am - 12:25pm
 
Length:
17 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Thomas R. Barr, MBA (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
120 - Management of Treatment-Related Toxicities in Melanoma 
Date/Time:
February 6, 2010   1:50pm - 2:20pm
 
Length:
64 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Barbara Pockaj, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
121 - Imaging and Radiation: Opportunities and Challenges 
Date/Time:
February 6, 2010   1:50pm - 2:50pm
 
Length:
31 Slides  
 
Total Credits:
1.00 CE / 1.00 CME  
 
Speakers:
Glenn Balasky (Speaker Disclosure)
 
Maria Madrigal Shaffer (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
122 - Adjuvant Therapy for Colon Cancer 
Date/Time:
February 6, 2010   2:20pm - 2:50pm
 
Length:
44 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
E. Scott Kopetz, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
123 - The Role of Surgery in Metastatic Colon Cancer 
Date/Time:
February 6, 2010   2:50pm - 3:20pm
 
Length:
39 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Michael A. Choti (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
124 - Accountable Care Organizations 
Date/Time:
February 6, 2010   2:50pm - 3:20pm
 
Length:
18 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speakers:
Patrick W. Cobb, MD (Speaker Disclosure)
 
Ted A. Okon, MBA (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
125 - Chemotherapy for Advanced Prostate Cancer 
Date/Time:
February 6, 2010   3:35pm - 4:05pm
 
Length:
28 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Tanya B. Dorff, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
126 - Practice Survival Strategies 
Date/Time:
February 6, 2010   3:35pm - 4:05pm
 
Length:
15 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Ricky Newton, CPA (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
127 - Biologic Therapy for Prostate Cancer 
Date/Time:
February 6, 2010   4:05pm - 4:35pm
 
Length:
30 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Tanya B. Dorff, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
128 - Helping Patients Understand and Enroll in Clinical Trials 
Date/Time:
February 6, 2010   4:05pm - 4:35pm
 
Length:
20 Slides  
 
Total Credits:
1.00 CE / 0.50 CME  
 
Speaker:
Deborah Collyar (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
October 17, 2009 - Saturday
 
rating
SA01 - Molecular Characteristics of NSCLC 
Date/Time:
October 17, 2009   8:10am - 8:45am
 
Length:
24m 31s - 36 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
John Minna, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA01 - Molecular Characteristics of NSCLC 
Date/Time:
October 17, 2009   8:10am - 8:45am
 
Length:
24m 31s - 36 Slides  
 
Speaker:
John Minna, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA03 - Molecular Testing in Breast Cancer 
Date/Time:
October 17, 2009   9:20am - 9:55am
 
Length:
32m 29s - 67 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Ronald H. Blum, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA03 - Molecular Testing in Breast Cancer 
Date/Time:
October 17, 2009   9:20am - 9:55am
 
Length:
32m 29s - 67 Slides  
 
Speaker:
Ronald H. Blum, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA04 - Latest Targeted Therapies for Breast Cancer 
Date/Time:
October 17, 2009   9:55am - 10:30am
 
Length:
31m 03s - 45 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Ruth O'Regan, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA04 - Latest Targeted Therapies for Breast Cancer 
Date/Time:
October 17, 2009   9:55am - 10:30am
 
Length:
31m 03s - 45 Slides  
 
Speaker:
Ruth O'Regan, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA05 - HspC90 as Emerging Therapy in HER2 + Breast Cancer 
Date/Time:
October 17, 2009   10:45am - 11:20am
 
Length:
17m 21s - 57 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Shanu Modi, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA05 - HspC90 as Emerging Therapy in HER2 + Breast Cancer 
Date/Time:
October 17, 2009   10:45am - 11:20am
 
Length:
17m 21s - 57 Slides  
 
Speaker:
Shanu Modi, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
EV01 - Evaluation for sessions SA01, SA03, SA04, SA05 
Date/Time:
October 17, 2009   11:19am - 11:19am
 
Total Credits:
3.25 CE  
 
Speakers:
Ronald H. Blum, MD (Speaker Disclosure)
 
John Minna, MD (Speaker Disclosure)
 
Shanu Modi, MD (Speaker Disclosure)
 
Ruth O'Regan, MD (Speaker Disclosure)
 

 
SA07 - mTor Pathways as a New Target in Endometrial and Ovarian Cancers 
Date/Time:
October 17, 2009   1:00pm - 1:35pm
 
Length:
19m 47s - 26 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Marcela Del Carmen, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA07 - mTor Pathways as a New Target in Endometrial and Ovarian Cancers 
Date/Time:
October 17, 2009   1:00pm - 1:35pm
 
Length:
19m 47s - 26 Slides  
 
Speaker:
Marcela Del Carmen, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA08 - Using Targeted Agents (EGFR and VEGF Inhibitors) as Radiation Modifiers 
Date/Time:
October 17, 2009   1:35pm - 2:10pm
 
Length:
26m 41s - 36 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
David B. Solit, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA08 - Using Targeted Agents (EGFR and VEGF Inhibitors) as Radiation Modifiers 
Date/Time:
October 17, 2009   1:35pm - 2:10pm
 
Length:
26m 41s - 36 Slides  
 
Speaker:
David B. Solit, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA09 - New Molecular Imaging Agents Provide a Better Look at Cancer 
Date/Time:
October 17, 2009   2:10pm - 2:45pm
 
Length:
25m 15s - 28 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Jerry Collins, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA09 - New Molecular Imaging Agents Provide a Better Look at Cancer 
Date/Time:
October 17, 2009   2:10pm - 2:45pm
 
Length:
25m 15s - 28 Slides  
 
Speaker:
Jerry Collins, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA10 - How to Enroll Patients in Clinical Trials 
Date/Time:
October 17, 2009   3:00pm - 3:35pm
 
Length:
37m 33s - 34 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Deborah Collyar (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA10 - How to Enroll Patients in Clinical Trials 
Date/Time:
October 17, 2009   3:00pm - 3:35pm
 
Length:
37m 33s - 34 Slides  
 
Speaker:
Deborah Collyar (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA11 - The Future of Oncology - Drugs in the Pipeline 
Date/Time:
October 17, 2009   3:35pm - 4:10pm
 
Length:
43m 03s - 31 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Bruce A. Chabner, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA11 - The Future of Oncology - Drugs in the Pipeline 
Date/Time:
October 17, 2009   3:35pm - 4:10pm
 
Length:
43m 03s - 31 Slides  
 
Speaker:
Bruce A. Chabner, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
EV02 - Evaluation for sessions SA07, SA08, SA09, SA10, SA11 
Date/Time:
October 17, 2009   4:10pm - 4:10pm
 
Total Credits:
3.50 CE  
 
Speakers:
Bruce A. Chabner, MD (Speaker Disclosure)
 
Jerry Collins, PhD (Speaker Disclosure)
 
Deborah Collyar (Speaker Disclosure)
 
Marcela Del Carmen, MD (Speaker Disclosure)
 
David B. Solit, MD (Speaker Disclosure)
 

 
September 24, 2009 - Thursday
 
rating
A101 - Introduction and Incidence and Mortality 
Date/Time:
September 24, 2009   1:00pm - 1:25pm
 
Length:
19m 16s - 46 Slides  
 
Total Credits:
0.25 CME/CE  
 
Speaker:
Leonard S. Sender, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
U101 - Prostate Cancer Screening: Where Do We Stand? 
Date/Time:
September 24, 2009   1:00pm - 1:30pm
 
Length:
36m 34s - 46 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Peter R. Carroll, MD, MPH (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM101 - Treatment of Newly Diagnosed Myeloma in Non-transplant Candidates 
Date/Time:
September 24, 2009   1:00pm - 1:30pm
 
Length:
18m 27s - 28 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Sagar Lonial, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
133 Results Found, Showing 1 - 50
Previous Page |   Go To Page:   | Next Page